Quarterly Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7290798

Concept As at
2024-09-30
2023-10-01 to
2024-09-30
As at
2023-09-30
2022-10-01 to
2023-09-30
As at
2022-09-30
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
5,367,000,000 JPY
2,887,000,000 JPY
Interest and dividends received
5,000,000 JPY
79,000,000 JPY
Interest paid
-194,000,000 JPY
-104,000,000 JPY
Income taxes paid
-1,026,000,000 JPY
-946,000,000 JPY
Net cash provided by (used in) operating activities
4,151,000,000 JPY
1,917,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,778,000,000 JPY
-3,327,000,000 JPY
Proceeds from sale of property, plant and equipment
2,000,000 JPY
10,000,000 JPY
Proceeds from sale of investment securities
5,356,000,000 JPY
JPY
Other, net
66,000,000 JPY
-1,000,000 JPY
Net cash provided by (used in) investing activities
-1,658,000,000 JPY
-5,240,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-4,610,000,000 JPY
-2,440,000,000 JPY
Proceeds from issuance of bonds
JPY
2,985,000,000 JPY
Redemption of bonds
-600,000,000 JPY
-300,000,000 JPY
Dividends paid
-972,000,000 JPY
-899,000,000 JPY
Net cash provided by (used in) financing activities
-435,000,000 JPY
1,915,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
202,000,000 JPY
185,000,000 JPY
Net increase (decrease) in cash and cash equivalents
2,260,000,000 JPY
-1,221,000,000 JPY
Cash and cash equivalents
4,585,000,000 JPY
2,324,000,000 JPY
3,546,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.